Fulgent Genetics (FLGT) Depreciation and Depletion (2017 - 2026)

Fulgent Genetics has disclosed Depreciation and Depletion across 10 years of filings, most recently posting $3.9 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $3.9 million, up 2.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.7 million (up 0.64% YoY), and the FY2025 annual result was $15.7 million, down 4.27% from the prior year.
• Depreciation and Depletion came in at $3.9 million for Q1 2026 at Fulgent Genetics, down from $4.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $7.6 million in Q3 2022 to a low of $3.7 million in Q1 2022.
• The 5-year median for Depreciation and Depletion is $4.0 million (2024), against an average of $4.6 million.
• Across the five-year window, Depreciation and Depletion jumped 204.0% in 2022 and sank 43.42% in 2023, its largest moves.
• Fulgent Genetics' Depreciation and Depletion stood at $7.6 million in 2022, then tumbled by 42.11% to $4.4 million in 2023, then decreased by 9.09% to $4.0 million in 2024, then advanced by 0.0% to $4.0 million in 2025, then declined by 2.5% to $3.9 million in 2026.
• The last three Depreciation and Depletion figures came in at $3.9 million (Q1 2026), $4.0 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.